1. Outcomes of Human Leukocyte Antigen–Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced- Intensity Conditioning Regimens 
Ronald M. Sobecks, Jose F. Leis, Robert Peter Gale, Kwang Woo Ahn, Xiaochun Zhu, Mitchell Sabloff, Marcos de Lima, Jennifer R. Brown, Yoshihiro Inamoto, Gregory A. Hale, Mahmoud D. Aljurf, Rammurti T. Kamble, Jack W. Hsu, Steven Z. Pavletic, Baldeep Wirk, Matthew D. Seftel, Ian D. Lewis, Edwin P. Alyea, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz, Wael Saber 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 9, Pages (September 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence curves comparing (A) grades II to IV and (B) grades III to IV acute GVHD, (C) chronic GVHD, (D) progression/relapse, and (E) TRM between MA and RIC allogeneic HCT for CLL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Comparison of progression-free survival between MA and RIC allogeneic HCT for CLL. (A) Performed in 2000 or earlier. (B) Performed after 2000.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Comparison of overall survival between MA and RIC allogeneic HCT for CLL. (A) Performed in 2000 or earlier. (B) Performed after 2000.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions